Edgewise Therapeutics has a 12 month low of $9.61 and a 12 month high of $38.12. The firm has a fifty day simple moving average of $29.65 and a 200 day simple moving average of $26.09. Get ...

For example, Edgewise Therapeutics (NASDAQ:EWTX) shareholders have done very well over the last year, with the share price soaring by 176%. Having said that, unprofitable companies are risky ...

Edgewise Therapeutics stock opened at $25.33 on Friday. Edgewise Therapeutics has a 52 week low of $9.00 and a 52 week high of $38.12. The firm’s 50-day simple moving average is $30.54 and its ...

January 13, 2025--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

We can readily understand why investors are attracted to unprofitable companies. For example, Edgewise Therapeutics (NASDAQ:EWTX) shareholders have done very well over the last year, with the share ...

Begin your TipRanks Premium journey today. Edgewise Therapeutics (EWTX) Company Description: Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today. The company’s shares closed yesterday at $25.33. Discover ...

Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease ...

January 13, 2025--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease ...